Montagu, Ares Said to Mull $1.4 Billion Euromedic Sale

March 19 (Bloomberg) -- The private-equity backers of health-care services operator Euromedic International are considering a sale of the company, according to three people with knowledge of the matter.

Euromedic has attracted interest from buyout firms and the company’s owners, including Ares Life Sciences and Montagu Private Equity LLP, could raise about 1 billion euros ($1.39 billion) from a sale, said the people, who asked not to be identified because the talks are private. A sales adviser hasn’t been hired, the people said.

The company, with its operational headquarters in Budapest, Hungary, provides services across Europe including diagnostic imaging, renal care and dialysis, clinical laboratory and radiotherapy services according to Montagu’s website. In 2011, Fresenius Medical Care AG & Co. bought Euromedic’s dialysis-services business in a deal valued at 485 million euros.

Montagu, Ares and Merrill Lynch Global Private Equity acquired Euromedic from Warburg Pincus LLC and GE Capital Equity Investments in 2008, according to Euromedic’s website.

Officials for Montagu and Ares declined to comment, while representatives for Euromedic and North Cove Partners, formerly Merrill Lynch Global Private Equity, didn’t respond to e-mailed requests seeking comment.

To contact the reporter on this story: Kiel Porter in London at kporter17@bloomberg.net

To contact the editors responsible for this story: Edward Evans at eevans3@bloomberg.net Jon Menon, Steve Bailey